Abpro Holdings Inc. (NASDAQ:ABP) Short Interest Update

by · The Markets Daily

Abpro Holdings Inc. (NASDAQ:ABP – Get Free Report) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totaling 10,134 shares, a drop of 46.8% from the December 15th total of 19,055 shares. Based on an average daily trading volume, of 10,788 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.4% of the shares of the stock are short sold. Currently, 0.4% of the shares of the stock are short sold. Based on an average daily trading volume, of 10,788 shares, the days-to-cover ratio is currently 0.9 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Goldman Sachs Group Inc. bought a new stake in shares of Abpro during the first quarter valued at approximately $30,000. Geode Capital Management LLC boosted its stake in Abpro by 127.6% during the second quarter. Geode Capital Management LLC now owns 196,494 shares of the company’s stock worth $42,000 after buying an additional 110,159 shares in the last quarter. Finally, Yorkville Advisors Global LP bought a new stake in Abpro in the 3rd quarter valued at $192,000. Institutional investors own 23.30% of the company’s stock.

Abpro Price Performance

Shares of NASDAQ ABP opened at $3.50 on Friday. Abpro has a one year low of $3.40 and a one year high of $42.59. The business’s 50-day moving average price is $5.30 and its two-hundred day moving average price is $6.17. The company has a market capitalization of $9.52 million, a P/E ratio of -0.83 and a beta of 0.02.

Abpro (NASDAQ:ABP – Get Free Report) last released its quarterly earnings data on Friday, November 14th. The company reported ($0.63) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.20) by $0.57.

Analyst Upgrades and Downgrades

ABP has been the topic of several recent research reports. Maxim Group lowered shares of Abpro from a “buy” rating to a “hold” rating in a research report on Tuesday, October 21st. Weiss Ratings restated a “sell (e+)” rating on shares of Abpro in a report on Monday, December 29th. Finally, Wall Street Zen lowered Abpro to a “strong sell” rating in a research report on Saturday, November 8th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Abpro has an average rating of “Reduce” and an average price target of $120.00.

Get Our Latest Report on Abpro

Abpro Company Profile

(Get Free Report)

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.

Featured Stories